Welcome to the summer issue of impactCancer. Immunotherapy is the next promising approach to cancer treatment and among our top priorities. This issue's cover story highlights Pelotonia's gift that will move us into the next frontier of cancer therapy and prevention with the formation of the Pelotonia Institute for Immuno-Oncology (PIIO).
Also in this issue, we look at how one couple’s philanthropy is helping push forward a clinical trial for ovarian cancer research. Jack Buttler is continuing their vision after his wife Joann’s passing, understanding the importance of clinical trials in moving cancer treatment forward.
The impact of philanthropy appears throughout this issue, as we also share how the generosity of donors has made it possible for JamesCare for Life to offer holistic cancer support programming for the last 25 years. Last but not least, we celebrate Don and Angie Ward for their commitment to future research initiatives.
This issue also highlights our next class of Pelotonia Fellows, some of Ohio State’s best and brightest students, whom we welcomed this past spring. They remind us – along with all the exciting work being highlighted in this issue – that together we will create a cancer-free world.
Raphael Pollock, MD, PhD
Director, The Ohio State University Comprehensive Cancer Center
William Farrar, MD
Interim CEO, James Cancer Hospital and Solove Research Institute